BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21131612)

  • 1. Tumour cryoablation combined with palliative bypass surgery in the treatment of unresectable pancreatic cancer: a retrospective study of 142 patients.
    Li J; Chen X; Yang H; Wang X; Yuan D; Zeng Y; Wen T; Yan L; Li B
    Postgrad Med J; 2011 Feb; 87(1024):89-95. PubMed ID: 21131612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcome of cryoablation in treating advanced pancreatic cancer: a comparison with palliative bypass surgery alone.
    Song ZG; Hao JH; Gao S; Gao CT; Tang Y; Liu JC
    J Dig Dis; 2014 Oct; 15(10):561-9. PubMed ID: 24958092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgical palliation for pancreatic cancer. The 25-year experience of a single reference centre].
    Popiela T; Kedra B; Sierzega M; Kubisz A
    Zentralbl Chir; 2002 Nov; 127(11):965-70. PubMed ID: 12476370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas.
    Müller MW; Friess H; Köninger J; Martin D; Wente MN; Hinz U; Ceyhan GO; Blaha P; Kleeff J; Büchler MW
    Am J Surg; 2008 Feb; 195(2):221-8. PubMed ID: 18154768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined biliary and gastric bypass procedures as effective palliation for unresectable malignant disease.
    Mann CD; Thomasset SC; Johnson NA; Garcea G; Neal CP; Dennison AR; Berry DP
    ANZ J Surg; 2009 Jun; 79(6):471-5. PubMed ID: 19566872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgery.
    Donahue TR; Isacoff WH; Hines OJ; Tomlinson JS; Farrell JJ; Bhat YM; Garon E; Clerkin B; Reber HA
    Arch Surg; 2011 Jul; 146(7):836-43. PubMed ID: 21768431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma.
    Berger AC; Meszoely IM; Ross EA; Watson JC; Hoffman JP
    Ann Surg Oncol; 2004 Jul; 11(7):644-9. PubMed ID: 15197014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of palliative biliary and gastric bypass surgery for pancreatic head carcinoma in 126 patients.
    van Wagensveld BA; Coene PP; van Gulik TM; Rauws EA; Obertop H; Gouma DJ
    Br J Surg; 1997 Oct; 84(10):1402-6. PubMed ID: 9361599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unresectable pancreatic carcinoma: correlating length of survival with choice of palliative bypass.
    Di Fronzo LA; Cymerman J; Egrari S; O'Connell TX
    Am Surg; 1999 Oct; 65(10):955-8. PubMed ID: 10515542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microscopically incomplete resection offers acceptable palliation in pancreatic cancer.
    Kuhlmann K; de Castro S; van Heek T; Busch O; van Gulik T; Obertop H; Gouma D
    Surgery; 2006 Feb; 139(2):188-96. PubMed ID: 16455327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of survival in patients treated for malignant biliary obstruction caused by unresectable pancreatic head cancer: surgical versus non-surgical palliation.
    Kim HO; Hwang SI; Kim H; Shin JH
    Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):643-8. PubMed ID: 19073412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of curative versus palliative surgical treatment for stage III pancreatic cancer patients.
    Kymionis GD; Konstadoulakis MM; Leandros E; Manouras A; Apostolou A; Alexiou D; Katsaragakis S; Androulakis G
    J R Coll Surg Edinb; 1999 Aug; 44(4):231-5. PubMed ID: 10453145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.
    Waraya M; Yamashita K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Watanabe M
    Ann Surg Oncol; 2009 May; 16(5):1231-40. PubMed ID: 19263172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study on radiofrequency ablation locally advanced pancreatic cancer.
    Casadei R; Ricci C; Pezzilli R; Serra C; Calculli L; Morselli-Labate AM; Santini D; Minni F
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):306-11. PubMed ID: 20525559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer.
    Kinsella TJ; Seo Y; Willis J; Stellato TA; Siegel CT; Harpp D; Willson JK; Gibbons J; Sanabria JR; Hardacre JM; Schulak JP
    Am J Clin Oncol; 2008 Oct; 31(5):446-53. PubMed ID: 18838880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of palliative hepaticojejunostomy and gastrojejunostomy in unresectable periampullary cancer: patient- and disease-related risk factors.
    Räty S; Sand J; Piironen A; Nordback I
    Hepatogastroenterology; 2006; 53(67):133-7. PubMed ID: 16506392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ?].
    Kobayashi N; Fujita K; Fujisawa T; Takahashi H; Yoneda M; Abe Y; Inamori M; Kirikoshi H; Kubota K; Saito S; Nakajima A
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):65-70. PubMed ID: 18195530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic head carcinoma: clinical analysis of 189 cases.
    Hua YP; Liang LJ; Peng BG; Li SQ; Huang JF
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):79-84. PubMed ID: 19208521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting factors for survival of patients with unresectable pancreatic cancer: a management guideline.
    Fujino Y; Suzuki Y; Ajiki T; Tanioka Y; Ku Y; Kuroda Y
    Hepatogastroenterology; 2003; 50(49):250-3. PubMed ID: 12630033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of combined therapy in pancreatic cancer with a poor prognosis: analysis of 233 clinical cases].
    Wang Y; Zhao P; Wang CF; Shan Y; Zhao DB; Tian YT; Sun YM; Che X; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2381-5. PubMed ID: 20137689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.